000 01075 a2200289 4500
005 20250513211031.0
264 0 _c20000725
008 200007s 0 0 eng d
022 _a0012-6667
024 7 _a10.2165/00003495-200059040-00016
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aClemett, D
245 0 0 _aProlonged-release mesalazine: a review of its therapeutic potential in ulcerative colitis and Crohn's disease.
_h[electronic resource]
260 _bDrugs
_cApr 2000
300 _a929-56 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAnimals
650 0 4 _aAnti-Inflammatory Agents, Non-Steroidal
_xadministration & dosage
650 0 4 _aColitis, Ulcerative
_xdrug therapy
650 0 4 _aCrohn Disease
_xdrug therapy
650 0 4 _aDelayed-Action Preparations
650 0 4 _aHumans
650 0 4 _aMesalamine
_xadministration & dosage
700 1 _aMarkham, A
773 0 _tDrugs
_gvol. 59
_gno. 4
_gp. 929-56
856 4 0 _uhttps://doi.org/10.2165/00003495-200059040-00016
_zAvailable from publisher's website
999 _c10755940
_d10755940